Moran, A., Ramakrishnan, S., Borg, C., Connolly, C., Couillard, S., Mwasuku, C., . . . Lehtimaki, L. (2020). Depletion rate of blood eosinophils with mepolizumab, benralizumab and oral prednisolone in patients with severe asthma. European Respiratory Society.
Chicago Style (17th ed.) CitationMoran, A., S. Ramakrishnan, C. Borg, C. Connolly, S. Couillard, C. Mwasuku, I. Pavord, T. Hinks, and L. Lehtimaki. Depletion Rate of Blood Eosinophils with Mepolizumab, Benralizumab and Oral Prednisolone in Patients with Severe Asthma. European Respiratory Society, 2020.
MLA citiranjeMoran, A., et al. Depletion Rate of Blood Eosinophils with Mepolizumab, Benralizumab and Oral Prednisolone in Patients with Severe Asthma. European Respiratory Society, 2020.
Opozorilo: Ti citati niso vedno 100% točni.